# Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

> **NCT00027976** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Precancerous Condition

## Interventions

- **DRUG:** celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00027976
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2001-12
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027976, "Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00027976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*